Taxus Cardium Pharmaceut... (CE) Quote - CRXM | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM) Share Price

Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM)

0.000001

0.00

(0.00%)

Closed 20 February 8:00AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

0.000001

Bid

0.00

Offer

0.00

Volume

-

0.00 Day's Range 0.00

0.000001 52 Week Range 0.000001

Previous Close

0.000001

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]

Angionetics To Present At 2015 LD Micro Invitational Investor Conference On Business And Generx® Phase 3 Clinical Developmen...

Angionetics To Present At 2015 LD Micro Invitational Investor Conference On Business And Generx® Phase 3 Clinical Development...

Angionetics Presents at the 2015 American Society of Gene & Cell Therapy Conference On Generx® Angiogenic Phase 3 Gene Thera...

Angionetics Presents at the 2015 American Society of Gene & Cell Therapy Conference On Generx® Angiogenic Phase 3 Gene Therapy Program PR...

Angionetics Presents At 2015 Annual Marcum MicroCap Conference On Business And Generx® Clinical Development Activities

Angionetics Presents At 2015 Annual Marcum MicroCap Conference On Business And Generx® Clinical Development Activities PR Newswire SAN DIEGO, May...

Angionetics Initial Equity Funding to Advance as Independent Company to Develop and Commercialize Phase 3 Generx® Gene Thera...

Angionetics Initial Equity Funding to Advance as Independent Company to Develop and Commercialize Phase 3 Generx® Gene Therapy Product...

Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx Angiogenic Microvascular ...

Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop, Market & Sell Generx Angiogenic Microvascular Gene Therapy In...

Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitat...

Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell...

Taxus Cardium Elects Three New Board Members Including PRC Strategic Investor Jiayue Zhang, John Wallace, U.S. Equity Trading...

Taxus Cardium Elects Three New Board Members Including PRC Strategic Investor Jiayue Zhang, John Wallace, U.S. Equity Trading Services Executive...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	1.0E-6	1.0E-6	1.0E-6	66750	1.0E-6	CS
52	0	0	1.0E-6	1.0E-6	1.0E-6	16611	1.0E-6	CS
156	0	0	1.0E-6	0.0001	1.0E-6	16398	1.202E-5	CS
260	-0.149999	-99.9993333333	0.15	0.17	1.0E-6	373718	0.05335512	CS

CRXM - Frequently Asked Questions (FAQ)

What is the current Taxus Cardium Pharmaceut... (CE) share price?

The current share price of Taxus Cardium Pharmaceut... (CE) is US$ 0.000001

What is the 1 year trading range for Taxus Cardium Pharmaceut... (CE) share price?

Taxus Cardium Pharmaceut... (CE) has traded in the range of US$ 0.000001 to US$ 0.000001 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RGRLFRio Grande Resources Ltd	0.07 (34,900.00%)	9k
TPIITriad Pro Innovators Inc (CE)	US$ 0.0002 (19,900.00%)	14k
HLLPFHello Pal International Inc (CE)	US$ 0.0002 (19,900.00%)	40.2k
AFIIQArmstrong Flooring Inc (CE)	US$ 0.0001 (9,900.00%)	10.89k
ONCIOn4 Communications Inc (PK)	US$ 0.0001 (9,900.00%)	6.4M
SPIEFSPI Energy Company Ltd (CE)	US$ 0.000001 (-100.00%)	59.69k
SHWZMedicine Man Technologies Inc (CE)	US$ 0.000001 (-100.00%)	2k
RQHTFReliq Health Technologies Inc (CE)	US$ 0.000001 (-99.99%)	350
NLVVFNew Leaf Ventures (PK)	US$ 0.000001 (-99.98%)	400
CDBTChina Dasheng Biotechnology Company (PK)	US$ 0.0003 (-99.63%)	1.17k
BOTYLingerie Fighting Championships Inc (PK)	US$ 0.0001 (0.00%)	443.07M
RONNRonn Motor Group Inc (PK)	US$ 0.0004 (33.33%)	433.99M
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.000001 (-99.50%)	133.05M
HMBLHUMBL Inc (PK)	US$ 0.0005 (0.00%)	111.65M
RDARRaadr Inc (PK)	US$ 0.0008 (0.00%)	94.31M

Gnarlyman

Gnarlyman 3 weeks ago

Seems dumb for an investor research firm to include a defunct company in this report.
https://www.einpresswire.com/article/778637651/gene-therapy-market-size-is-expected-to-reach-usd-29-24-billion-by-2033-growing-at-a-cagr-of-18-60-straits-research

bentleyt

bentleyt 3 weeks ago

Altitrade As Far As You Folks See Is CRXM Having Any Success Funding The Generx Phase 3 ?.....Absolutely Zero Updates To Shareholders From The Company

crazyflavor

crazyflavor 1 month ago

Here is what your likely to hear if you want to file a lawsuit:

-What is the basis for your complaint / lawsuit?
-What are your damages?
-How are you going to prove that laws were broken?
-Is this a class action lawsuit?
-What attorney / law firm with experience to do so is going to take this case?
-Are you suing Nostrum, CRXM (bc CRXM seems pretty judgement proof) or both?

*Attorneys are expensive, I can't imagine one taking this on spec and you'd probably spend more trying to get back what you lost. I've been in litigation 2x and both of those have taken well over a yr to resolve. Courts don't move quickly.

bentleyt

bentleyt 2 months ago

October 30 2023....Nostrum and its founder and CEO Nirmal Mulye settled with the DOJ for underpaying Medicaid rebates....They are fined and have agreed to pay anywhere from $3,825,000 to $50,000,000.....This hurt CRXM shareholders as they have basically abandoned the company.....The company never filed their financials in a timely fashion and the stock is currently delisted with zero value....IMHO Shareholders should consider legal recourse if things don't turn around in a reasonable timely fashion

👍️ 4 💯 3

campe

campe 2 months ago

Nostrum needs to let go the reigns and let the market blow some life back into this thing, before anyone catches up and leaves their CRXM tech in the dust.

bentleyt

bentleyt 2 months ago

JJ24....Whats Up....I Sent You A Private Message

docj

docj 2 months ago

My understanding and I may be misinformed, the offer was arounf $10 million. Why would Nostrum turn down such a sum given the situation they are/were in?

There is a potential asset woth minimally hunfreds of millions to Nostrum/CRXM and between the 2 companies they can't make a deal for one or the other to be purchased outright or raise $20-25 million to get to the finish line within a year or two?

Something isn't right with this picture.

Altitrade Partners

Altitrade Partners 2 months ago

It wasn't significant enough, I guess.

docj

docj 2 months ago

Didn't CRXM try to buy Nostrum out fairly recently and Nostrum turned down a significant amount of money?

Altitrade Partners

Altitrade Partners 2 months ago

Nostrum would need to buy into that idea and I'm not sure they would.

campe

campe 2 months ago

If he can't raise the $$, why not just sell to a larger pharma? At least his research would move forward and not die on the wine.

It must be worth something to someone...

Altitrade Partners

Altitrade Partners 2 months ago

Nothing has changed, and the stock will likely never trade again. The future of the GeneRx clinical trial can only be secured if Chris Reinhard raises the capital required (approximately $25 million) to fund the next step to move to a Phase 3 trial. The results from the clinical trial will determine what happens from there. I have chosen not to write this off as a tax deduction since there is still a glimmer of hope, albeit a very small one.

docj

docj 2 months ago

Altitrade Partners:

The below post was from a few months ago. Has your thinking changed any as time has passed and we are at years end? I personally have one of my family members wondering if they should take a tax loss at this point on their CRXM position.

Altitrade Partners

Re: bentleyt post# 6166

Friday, September 06, 2024 9:40:40 AM

Post#
6167
of 6188
It depends on three things:

1. They can obtain funding for a Phase 3 clinical trial of GeneRx.
2. They get a favorable outcome and FDA approval of the drug.
3. They can attract a Big Pharma company to purchase the drug.

I doubt that this company's shares will ever trade again. Instead, CRXM will likely implement an exit strategy for its shareholders based on the above, where the shareholders receive a portion of the proceeds based on any sale of GeneRx.

As I have often said, shareholders should view this as an investment in a private company.
"All truth passes through three stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident." ~ Arthur Schopenhauer

bentleyt

bentleyt 2 months ago

docj.....Yes It Would Be Nice If The Company Would Provide Some Kind Of Update....Complete Disregard Of Shareholders.....Regardless Also Wishing Everyone A Happy And Healthy Holiday Season

docj

docj 2 months ago

Anything on the funding?

I wish everyone a great holiday and Happy New Year!

docj

docj 4 months ago

I was told to expect CR to respond to the SEC. Apparently he did not.

I'm not sure if CRXM even exists as a company at this point.

I am extremely disappointed in the CRXM management team for not communicating an update with shareholders.

docj

docj 4 months ago

https://www.sec.gov/files/litigation/opinions/2024/34-101312.pdf

Gnarlyman

Gnarlyman 4 months ago

When did CRXM disappear from OTC, anyone else unable to search the ticker?

docj

docj 4 months ago

I’m giving up my moderator position here on the CRXM board. Anyone interested in jumping in is welcome to do so.

Best to you all.

benyam

benyam 4 months ago

why they updare website it s donw ????

benyam

benyam 4 months ago

i m mostly ao sad trial was allmost done shareholder loose and people loose amazing that no financong or whatever

docj

docj 4 months ago

Does anyone know if a new entity has been formed and if our CRXM common shares affords us an ownership interest is this new entity?

👍️ 1 🙏 2

docj

docj 4 months ago

OTC Markets didn't find anything for CRXM when I checked. Given the SEC's latest letter to Gene Bio, can't say I am surprised. I will say I'm disappointed in CR at the moment. The least he could do is put a banner on the company website providing some clarity on where things stand. Chris, do the right thing and give shareholders an update!

bentleyt

bentleyt 4 months ago

See Altitrade post 9/6/24.....They believe we have shares in what will become a private company.....Hopefully they raise the $ for the Phase 3 Generx Trial

👍️ 1 😉 1

benyam

benyam 4 months ago

yeah but crxm have been delister so our story is over

bentleyt

bentleyt 4 months ago

The CEO picked bad partners with Nostrum.....Now trying to raise $20,000,000 for Phase 3 Generx trial....How about getting a real deal Biotech involved.....CRXM has to get Nostrum out of the picture!

benyam

benyam 4 months ago

difficult to understand that crxm saga didn t continue to last trial

benyam

benyam 4 months ago

so we are delisted now

Renee

Renee 4 months ago

CRXM SEC registration revoked:

https://www.sec.gov/files/litigation/opinions/2024/34-101312.pdf

docj

docj 4 months ago

Any information on how much success there has been raising money for the trial?

I’m not sure about trading again. It will require a huge investment to get current. Unless CR has come up with another project to pursue that being a public traded company would be of benefit. Or another indication for Generx that gets carved out from the hoped for trial and new investors.

JJ24

JJ24 4 months ago

Spoken to Rinehardt a few times over the last few months . He always says he’s working on it . If we trade again it will sky rocket .

👍️ 3 🙏 1

benyam

benyam 4 months ago

tick tock bit when boom it s big question if never

bentleyt

bentleyt 5 months ago

Altitrade....Appreciate your take on the situation....We have to hope for the best

benyam

benyam 5 months ago

only i ll can tell it s amazing that they don t have get money injection from some big pharma

Altitrade Partners

Altitrade Partners 5 months ago

It depends on three things:

1. They can obtain funding for a Phase 3 clinical trial of GeneRx.
2. They get a favorable outcome and FDA approval of the drug.
3. They can attract a Big Pharma company to purchase the drug.

I doubt that this company's shares will ever trade again. Instead, CRXM will likely implement an exit strategy for its shareholders based on the above, where the shareholders receive a portion of the proceeds based on any sale of GeneRx.

As I have often said, shareholders should view this as an investment in a private company.

bentleyt

bentleyt 6 months ago

Altitrade....What Do You Think Of The Future Of This Company ???

benyam

benyam 6 months ago

docj

docj 6 months ago

Any unofficial updates regarding CRXM?

benyam

benyam 6 months ago

it s amazing that cannpt get financing to phase 3 soo big market possibilities

docj

docj 6 months ago

I understand CYDY has used AI to come up with additional formulas and indications for leronlimab. Unfortunately I don't think Chris has the money to do anything like that although it could present some options.

3 months or more since I have been aware of the $20m plan. Be nice to hear an update.

bentleyt

bentleyt 6 months ago

Right now Chris should use AI and come up with a list of strong pharmaceutical companies and investors.....The $20,000,000 could be raised easily....Lets replace Nostrum with some good people!

JJ24

JJ24 7 months ago

Every conversation I have had with Chris which he can’t say much but I believe he’s doing everything he can to get phase 3 going . We were so close to having phase 3 started with FUJIFILM Diosynth Biotechnologies. If Nostrum didn’t get hammered by the DOJ for up to $50 million we would have been in phase 3 . If Chris gets us trading again and in phase 3 I will retire early from this play . If not I am on Track to working till i am in my grave .

benyam

benyam 7 months ago

crxm website are active anyways

docj

docj 7 months ago

If the company stays private, there needs to be a way to connect shareholders to buy and sell shares. I owned a shares of stock in a local community bank that was growing its business. The President of the bank had a list of buyers and sellers he would connect. Eventually a link on the banks website allowed shareholders to deal directly with each other.

docj

docj 7 months ago

It would be nice to hear progress details. I'm keeping my fingers crossed CR will be able to put the financing together to move forward with the study. It will be interesting to hear what is in store for CRXM as a company and common shareholders.

JJ24

JJ24 7 months ago

I got this feeling we hear something soon .

docj

docj 7 months ago

Hey, BTW, I just saw your private reply post to me from back in May.

I do have the document but I won't share more since I did the super secret handshake. LOL. Perhaps CR will make it available soon.

crazyflavor

crazyflavor 7 months ago

Do you have a link to the pp? I don’t see it anywhere

BlueChip$

BlueChip$ 8 months ago

So you're saying there's a chance!...YES!

campe

campe 8 months ago

Thanks for posting. Good to see there is still some life and hope for CRXM.

Taxus Cardium Pharmaceut... (CE)

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions